- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for KDL Biotech Ltd (KOPD)
| Open: | 1.96 | Day's Range: | 1.96 - 1.96 | Volume: | 400 |
|---|---|---|---|---|---|
| Previous Close: | 2.00 | 52wk Range: | 1.85 - 4.40 | 1-Yr Rtn: | -44.00% |
Key Statistics for KOPD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | - |
| Earnings Per Share (ttm) | -7.1700 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 47.11 |
| Shares Outstanding (M) | 24.04 |
| 30 Day Average Volume | 439 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.5541 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (INR) | - |
| Last Dividend | 09/25/2006 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for KOPD
No data available
Company Profile & Key Executives for KOPD
KDL Biotech Limited manufactures biotechnology based products. The Group specializes in Semi-synthetic Penicillins and related Enzymes. KDL Biotech has a joint venture with Synpac Pharmaceuticals to develop Penicillin-related products.
| Nalin BamzaiManaging Director | Rajesh AgrawalDirector:Technical |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
KOPD News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page